Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,560.36
(
-0.70%
)
US TECH 100
23,478.40
(
-1.02%
)
Dow Jones
45,818.66
(
-0.44%
)
Brent Oil
106.65
(
2.12%
)
Bitcoin
70,054.00
(
0.22%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

indigokid

Send PM Follow Ignore
Followers 3
Posts 231
Boards Moderated 0
Alias Born 07/28/2011

indigokid

Re: Bickema post# 208155

Wednesday, 01/18/2017 5:22:27 PM

Wednesday, January 18, 2017 5:22:27 PM

Post# of 257262
After reading this article I think Barclays is incorrect. I think MNTA has specifically planned for all of the guidelines for an interchangeable Humira. Amgen went for biosimilar not interchangeable as have most other players and will likely miss the bar for interchangeability.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today